Loading patent…
OwnerChunlin XIONG, Yunxia HE +2inventors
InventorsChunlin XIONG, Yunxia HE, Yajun ZUO, Gang YU
Estimating the term…
Disclosed herein is an insulinotropic peptide multi-dose aqueous parenteral pharmaceutical composition and use thereof. A long-term storage formulation of the insulinotropic peptide can be obtained via the method of the present disclosure. The pharmaceutical composition of the present disclosure comprises: insulinotropic peptide, insulinotropic peptide analogue and derivative; pharmaceutically acceptable tonicity modifier (stabilizer); pharmaceutically acceptable preservative; and pharmaceutically acceptable dissolution enhancer and pharmaceutically acceptable buffer solution. The pharmaceutical composition of the insulinotropic peptide is used in the preparation of drugs for treating diabetes and adiposis.
An aqueous parenteral pharmaceutical composition comprising an insulinotropic peptide, a pharmaceutically acceptable osmotic agent, a pharmaceutically acceptable preservative, a pharmaceutically acceptable dissolution enhancer, and a pharmaceutically acceptable buffer salt solution, wherein:
Dependencies are inferred from the claim text.